Latest news
Loading news…
CT Atlantic
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Schlieren, Zurich, Switzerland Founded 2008 1-10 employees For Profit
CT Atlantic AG is a swiss biotech company researches and develops novel, human-derived antibodies for the treatment of cancer.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
4
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 0
- Patents granted
- 4
- Trademarks
- 0
- Top patent class
- Organic Chemistry
- IT spend
- $9M
Company Info
- Founded
- 2008
- Employees
- 1-10
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- HQ
- Schlieren, Zurich, Switzerland
- Region
- Europe, Middle East, and Africa (EMEA)
- Closed
- Aug 11, 2020
Signals & Scores
- Heat score
- Low
- Trend (7d)
- -0.5
- Trend (30d)
- -2.3
- Trend (90d)
- -0.5
Key People at CT Atlantic
CTO
Co-Founder & CEO
CEO
COO
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to CT Atlantic
Loading news…
FAQs about CT Atlantic
People who checked this page also checked these
Browse the full Acquirezy directory.